Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Sentinel Lymph Node Biopsy
Maui, Hawaii - Nodal staging with sentinel lymph node biopsy (SLN) is warranted in all patients with malignant melanoma at risk for nodal metastasis, and patients with a positive SLN should undergo therapeutic lymph-node dissection and be counseled about the opportunity for adjuvant therapy with interferon alfa-2b (Intron A) or participation in ongoing clinical trials, Kelly M. McMasters, M.D., Ph.D, said at the annual Hawaii Dermatology Seminar, sponsored by the Skin Disease Education Foundation.
Recent Videos
Related Content
